Alector, Inc. Shareholders' Equity
Alector, Inc. (ALEC) had Shareholders' Equity of -$9.97 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent -$9.97M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.38M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $30.65M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $57.71M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$9.97M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $10.38M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $30.65M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $57.71M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $71.17M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $94.61M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $126.80M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $118.93M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $150.57M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $178.91M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $134.16M 10-K · filed 2026-02-25 |
| 2023-09-30 | $162.56M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $196.31M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $183.01M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $214.44M 10-K · filed 2025-02-26 |
| 2022-09-30 | $253.10M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $288.52M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $267.54M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $300.72M 10-K · filed 2025-02-26 |
| 2021-09-30 | $335.89M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $184.51M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $227.83M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $267.53M 10-K · filed 2024-02-27 |
| 2020-09-30 | $310.19M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $355.33M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $391.73M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $194.74M 10-K · filed 2023-02-28 |
| 2019-09-30 | $218.59M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $245.72M 10-Q · filed 2020-11-10 |
| 2019-03-31 | $266.19M 10-Q · filed 2020-11-10 |
| 2018-12-31 | -$97.40M 10-K · filed 2022-02-24 |
| 2018-09-30 | -$82.78M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$69.40M 10-Q · filed 2019-11-12 |
| 2018-03-31 | -$59.50M 10-Q · filed 2019-11-12 |
| 2017-12-31 | -$52.03M 10-K · filed 2021-02-25 |
| 2016-12-31 | -$24.91M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |